OrphoMed: OrphoMed to Present at the 2018 BIO CEO & Investor Conference

SAN FRANCISCO, Jan. 31, 2018 /PRNewswire/ - OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, announced today that Nikhilesh N. Singh, Ph.D., President and Chief Executive Officer, will present at the 20th...